{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:08:31Z","timestamp":1790665711038,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jcf.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T23:31:10Z","timestamp":1553729470000},"page":"436-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose"],"prefix":"10.1016","volume":"18","author":[{"given":"Inger Hee","family":"Mathiesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2195-8552","authenticated-orcid":false,"given":"Mette Friberg","family":"Hitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese Lea","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9828-9185","authenticated-orcid":false,"given":"Peter","family":"Oturai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Oestrup","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Raaberg","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Krogh-Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacjana","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Faurholt-Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2019.01.004_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prrv.2009.05.001","article-title":"Update on cystic fibrosis-related bone disease: a special focus on children","volume":"10","author":"Sermet-Gaudelus","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2019.01.004_bb0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2019.01.004_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcf.2019.01.004_bb0020","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"Diabetes mellitus, a state of low bone turnover-a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcf.2019.01.004_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1097-4644(20001101)79:2<301::AID-JCB130>3.0.CO;2-0","article-title":"Extracellular glucose influences osteoblast differentiation and c-jun expression","volume":"79","author":"Zayzafoon","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jcf.2019.01.004_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jcb.20842","article-title":"Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways","volume":"99","author":"Botolin","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jcf.2019.01.004_bb0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bone.2005.04.039","article-title":"The effects of local insulin delivery on diabetic fracture healing","volume":"37","author":"Gandhi","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.jcf.2019.01.004_bb0040","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00198-014-2714-5","article-title":"Suppressed Bone Turnover Was Associated With Increased Osteoporotic Fracture Risks in Non-Obese Postmenopausal Chinese Women With Type 2 Diabetes Mellitus","volume":"25","author":"Jiajue","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcf.2019.01.004_bb0045","doi-asserted-by":"crossref","first-page":"43399","DOI":"10.1038\/srep43399","article-title":"Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2019.01.004_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4803974","article-title":"Osteoporosis is associated with deteriorating clinical status in adults with cystic fibrosis","author":"Mathiesen","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.jcf.2019.01.004_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","article-title":"Update on Cystic Fibrosis-Related Diabetes","volume":"12","author":"Kelly","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.01.004_bb0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00198-005-0058-x","article-title":"Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis conclusions\u2014these findings may have therapeutic implications for enhancing bone density in these patients","volume":"17","author":"Gordon","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcf.2019.01.004_bb0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/thorax.57.8.719","article-title":"A prospective study of change in bone mineral density over one year in adults with cystic","volume":"57","author":"Haworth","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2019.01.004_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00774-014-0572-z","article-title":"Factors associated with low bone mineral density in patients with cystic fibrosis","volume":"33","author":"Sheikh","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jcf.2019.01.004_bb0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/ajrccm.162.3.9910118","article-title":"Bone density, body composition, and inflammatory status in cystic fibrosis","volume":"162","author":"Ionescu","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2019.01.004_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcf.2009.11.007","article-title":"Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis","volume":"9","author":"Shead","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.01.004_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrd3669","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcf.2019.01.004_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of Spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"European Respiratory"},{"issue":"6","key":"10.1016\/j.jcf.2019.01.004_bb0095","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic Reference Values for Spirometry for the 3\u201395-yr Age Range: The Global Lung Function 2012 Equations Stocks and the ERS Global Lung Function Initiative","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2019.01.004_bb0100","series-title":"2013 Position Development Conference on Bone Densitometry Executive Summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Bone Densitometry","author":"Schousboe","year":"2013"},{"key":"10.1016\/j.jcf.2019.01.004_bb0105","first-page":"1","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.jcf.2019.01.004_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcf.2019.01.004_bb0115","series-title":"R A Lang. Environ. Stat. Comput","author":"R Core Team","year":"2008"},{"key":"10.1016\/j.jcf.2019.01.004_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcf.2019.01.004_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbspin.2015.04.021","article-title":"Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis","volume":"83","author":"Baker","year":"2016","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.jcf.2019.01.004_bb0130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/thx.54.11.961","article-title":"Low bone mineral density in adults with cystic fibrosis","volume":"54","author":"Haworth","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2019.01.004_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2015.11.004","article-title":"Differences in biochemical bone markers by diabetes type and the impact of glucose","volume":"83","author":"Starup-Linde","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jcf.2019.01.004_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1155\/2014\/235060","article-title":"Effect of GH\/IGF-1 on bone metabolism and Osteoporsosis","volume":"2014","author":"Locatelli","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jcf.2019.01.004_bb0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/eje.0.1400315","article-title":"Normal spontaneous and stimulated GH levels despite decreased IGF-I concentrations in cystic fibrosis patients","volume":"140","author":"Laursen","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcf.2019.01.004_bb0150","first-page":"162","article-title":"Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines","volume":"66","author":"Street","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/j.jcf.2019.01.004_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jbspin.2011.05.009","article-title":"Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers","volume":"79","author":"Legroux-G\u00e9rot","year":"2012","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.jcf.2019.01.004_bb0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/09031936.04.00050204","article-title":"Reduced bone density in cystic fibrosis: F508 mutation is an independent risk factor","volume":"25","author":"King","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2019.01.004_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.200307-1049OC","article-title":"Efficacy of alendronate in adults with cystic fibrosis with low bone density","volume":"169","author":"Aris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2019.01.004_bb0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.08-0608","article-title":"Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial)","volume":"134","author":"Papaioannou","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2019.01.004_bb0175","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcf.2019.01.004_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials","volume":"48","author":"Su","year":"2015","journal-title":"Endocrine"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318308099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318308099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:10Z","timestamp":1761601270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318308099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1569199318308099"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.01.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}